Mostrar el registro sencillo del ítem
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
dc.contributor.author | Sanchez-Piedra, C. | |
dc.contributor.author | Diaz-Torne, C. | |
dc.contributor.author | Manero, J. | |
dc.contributor.author | Pego Reigosa, José María | |
dc.contributor.author | Rua-Figueroa, I. | |
dc.contributor.author | Gonzalez-Gay, M. A. | |
dc.contributor.author | Gómez-Reino Carnota, Juan Jesús | |
dc.contributor.author | Alvaro-Gracia, J. M. | |
dc.contributor.author | Biobadaser Study Group | |
dc.date.accessioned | 2022-05-05T08:29:03Z | |
dc.date.available | 2022-05-05T08:29:03Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.other | https://www.ncbi.nlm.nih.gov/pubmed/32503857 | es |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/16693 | |
dc.rights | Atribución-NoComercial 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject.mesh | Spondylarthropathies | * |
dc.subject.mesh | Rheumatic Diseases | * |
dc.subject.mesh | Pandemics | * |
dc.subject.mesh | Adult | * |
dc.subject.mesh | Middle Aged | * |
dc.subject.mesh | Coronavirus Infections | * |
dc.subject.mesh | Glucocorticoids | * |
dc.subject.mesh | Pneumonia | * |
dc.subject.mesh | Methotrexate | * |
dc.subject.mesh | Arthritis | * |
dc.subject.mesh | Antibodies | * |
dc.subject.mesh | Hospitalization | * |
dc.subject.mesh | Humans | * |
dc.subject.mesh | Antirheumatic Agents | * |
dc.subject.mesh | Interleukin 1 Receptor Antagonist Protein | * |
dc.subject.mesh | Hydroxychloroquine | * |
dc.subject.mesh | Intensive Care Units | * |
dc.subject.mesh | Aged | * |
dc.title | Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies | en |
dc.type | Journal Article | es |
dc.authorsophos | Sanchez-Piedra, C.;Diaz-Torne, C.;Manero, J.;Pego-Reigosa, J. M.;Rua-Figueroa, I.;Gonzalez-Gay, M. A.;Gomez-Reino, J.;Alvaro-Gracia, J. M.;Grp, Biobadaser Study | |
dc.identifier.doi | 10.1136/annrheumdis-2020-217948 | |
dc.identifier.pmid | 32503857 | |
dc.identifier.sophos | 39959 | |
dc.issue.number | 7 | es |
dc.journal.title | Annals of the rheumatic diseases | es |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Reumatoloxía | es |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Vigo - Complexo Hospitalario Universitario de Vigo::Reumatoloxía | es |
dc.page.initial | 988 | es |
dc.page.final | 990 | es |
dc.rights.accessRights | openAccess | |
dc.subject.decs | pandemias | * |
dc.subject.decs | glucocorticoides | * |
dc.subject.decs | mediana edad | * |
dc.subject.decs | anticuerpos | * |
dc.subject.decs | adulto | * |
dc.subject.decs | antirreumáticos | * |
dc.subject.decs | anciano | * |
dc.subject.decs | neumonía | * |
dc.subject.decs | metotrexato | * |
dc.subject.decs | hospitalización | * |
dc.subject.decs | enfermedades reumáticas | * |
dc.subject.decs | humanos | * |
dc.subject.decs | espondiloartropatías | * |
dc.subject.decs | unidades de cuidados intensivos | * |
dc.subject.decs | hidroxicloroquina | * |
dc.subject.decs | infecciones por Coronavirus | * |
dc.subject.decs | artritis | * |
dc.subject.decs | proteína antagonista del receptor de interleucina 1 | * |
dc.subject.keyword | CHUS | es |
dc.subject.keyword | CHUVI | es |
dc.typefides | Artículo Original | es |
dc.typesophos | Artículo Original | es |
dc.volume.number | 79 | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial 4.0 Internacional
![](/xmlui/themes/Mirage2//images/final_lines.png)